An interventional study of Dialectical Behavior Therapy for Justice-Involved Veterans and Supportive Group Psychotherapy for Justice-Involved Veterans in Criminal Behavior, Criminal Recidivism and Psychosocial Functioning, sponsored by VA Office of Research and Development. Active, not recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Recidivism with a site in United States — 3 open to participants now, 7 under way, 1 of them phase 3. Recidivism · United States.
Among the 26 studies in Recidivism with a site in United States, this one is the 15th largest by enrollment of the 25 interventional ones that give a count, is the only one that started in 2024, is one of 20 with no phase, and was the 23rd registered.
32 studies on the registry are indexed under Recidivism; 7 are open to participants now.
Browse Recidivism studies →3 of the 26 studies in Recidivism with a site in United States are open now. Recruiting first, the newest first:
University of Arkansas · Sites in United States
Ages 18+
University of Pennsylvania · Sites in United States
Ages 18+
Iowa State University · Sites in United States
Ages 18+ · Men only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 4 Recidivism studies recruiting now, 3 set no upper age limit and 1 stops at 75 or younger; none take children under 18; none take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 2
First in 2007; this study’s year is marked. 1 started in 2024.
This study's enrollment of 215 is below the median of 248 across 30 interventional studies indexed under Recidivism.
Median enrollment 256 across the 25 interventional studies, 800 across the 1 observational. Of the 16 that completed or were terminated, 4 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 26 have an industry lead sponsor. The 10 most frequent:
VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
VA Office of Research and Development has 1 study filed under Recidivism — fewer than ten, so there is no comparison to draw.
4 of the studies in Recidivism with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05696353Phase 3Ginger YangTeen Driving Translation Study (NIH) | 2026-12-31 |
| NCT05109689Iowa State UniversityA Randomized Controlled Trial of ACT-P Versus T4C for Community Reentry | 2026-12 |
| NCT04386681Rehabilitation Hospital of IndianaRe-entry Continuum for Brain Injury | 2027-01-01 |
| NCT05974553VA Office of Research and DevelopmentDialectical Behavior Therapy for Justice-Involved Veterans | 2027-06-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 26 studies in Recidivism with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is a comprehensive, integrative program distinctively designed to address the range of mental health, substance use, case management, and legal needs of Veterans with current or ongoing criminal justice involvement. Data from two prior clinical trials attest to the program's feasibility and acceptability and preliminarily suggest participation in the program may yield meaningful improvements in risk for criminal behavior and resolution of high-priority case management needs. However, continued research is needed to further investigate the program's efficacy. This Phase III clinical trial aims to investigate the superiority of DBT-J over a supportive group therapy treatment in decreasing risk of future criminal behavior and increasing psychosocial functioning. Secondary and exploratory aims will also investigate superiority of DBT-J in improving secondary treatment targets, potential differential efficacy across special-interest Veteran subgroups, and long-term consequences of program participation.
Despite substantial efforts to curb Veteran suicide, Veterans continue to die by suicide at rates that far exceed their civilian peers. To date, substantial resources have been invested into understanding and treating underlying risk factors and precipitants of Veteran suicide. However, criminal justice involvement remains an under-examined and under-assessed risk factor for Veteran suicide. Accumulating research suggests justice-involved Veterans are a high-risk, high need population, particularly within the Veterans Health Administration. For example, 11% of Veteran suicides are precipitated by legal troubles; 79% of Veterans receiving VA supportive housing assistance have a history of one or more arrests; and 58% of Veterans receiving outpatient VHA substance use treatment have a history of three or more arrests. Risk for suicide among justice-involved Veterans is particularly elevated among those with co-occurring difficulties, such as mental health concerns and/or housing instability. Adequately addressing Veteran suicide - both for justice-involved Veterans and the broader Veteran population - therefore likely requires interventions to address the legal and co-occurring difficulties of at-risk Veterans.
Dialectical Behavior Therapy for Justice-Involved Veterans (DBT-J) is distinctively designed to address these range of needs faced by justice-involved Veterans, including heightened suicide risk, antisocial behaviors, mental health and substance use concerns, community-based structural barriers, and case management difficulties. Combining elements of three prominent, evidence-based models, DBT-J provides 16 weeks of group psychotherapy, case management services, and measurement-based care to Veterans with ongoing or recent criminal justice involvement. Data from two prior clinical trials attest to the feasibility and acceptability of DBT-J within VHA behavioral health settings. Although preliminary, data also suggest participation in DBT-J may yield meaningful reductions in risk for future criminal behavior and resolution of high-priority case management needs. Continued research, however, is needed to further investigate the program's efficacy.
Toward these aims, this Phase III clinical trial will:
Up to 250 Veterans with current or recent involvement in the criminal justice system will be recruited from the greater New York City, New York and Denver, Colorado areas to participate in this clinical trial. Veterans will be randomly assigned to receive either 16 weeks of DBT-J or 16 weeks of supportive group therapy followed by a 36 week observational period. Comprehensive assessments of Veteran risk for future criminal justice involvement, psychosocial functioning, suicidal ideation, criminogenic thinking, psychological distress, substance use, case management needs, quality of life, resilience, suicide-related behavior, and criminal recidivism will be administered periodically throughout study completion. Analyses of variance will then be used to compare study conditions on primary and secondary treatment targets and to compare high-priority participant subgroups on primary and secondary treatment targets.
32 studies on the registry are indexed under Recidivism; 7 are open to participants now.
This study's enrollment of 215 is below the median of 248 across 30 interventional studies indexed under Recidivism.
Browse Recidivism studies →VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
Compared within Recidivism, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Criminal Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →
The criteria were revised on the registry on Oct 26, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Current or recent history of criminal justice involvement, defined as
Exclusion Criteria:
16 weeks of Dialectical Behavior Therapy for Justice-Involved Veterans
Behavioral: Dialectical Behavior Therapy for Justice-Involved Veterans
16 weeks of supportive group psychotherapy for justice-involved Veterans
Behavioral: Supportive Group Psychotherapy for Justice-Involved Veterans
16 weeks of Dialectical Behavior Therapy for Justice-Involved Veterans, including weekly 60-minute group therapy and biweekly 30-minute individual case management
16 weeks of clinician-facilitated supportive group psychotherapy for justice-involved Veterans, including weekly 75-minute group psychotherapy (20 hours total intervention). All interventions delivered via telehealth.
Level of Service / Case Management Inventory
semi-structured interview assessment of risk for future criminal justice involvement; score range = 0-43, with higher scores indicating greater risk for future criminal justice involvement
Time frame: Six times over course of 52 weeks
Inventory of Psychosocial Functioning
self-report instrument measuring functional impairments in romantic relationships, family relationships, work, friendships and socializing, parenting, education, and self-care; score range = 0-100, with higher scores indicating greater impairment in psychosocial functioning
Time frame: Six times over course of 52 weeks
Beck Scale for Suicidal Ideation
self-report instrument measuring nature, frequency, and intensity of suicidal ideation; score range = 0-38, with higher scores indicating greater severity of suicidal ideation
Time frame: Six times over course of 52 weeks
The Measure of Criminogenic Thinking Styles
self-report instrument measuring tendency to adopt thinking styles commonly associated with engagement in criminal behavior; score range = 65-325, with higher scores indicating greater tendency to engage in criminogenic thinking styles
Time frame: Three times over course of 52 weeks
Patient Health Questionnaire-9
self-report instrument measuring psychological distress; score range = 0-27, with higher scores indicating greater psychological distress
Time frame: Six times over course of 52 weeks
Alcohol Use Disorders Identification Test
self-report instrument measuring frequency and volume of alcohol use; score range = 0-40, with higher scores indicating more severe alcohol use
Time frame: Six times over course of 52 weeks
Drug Abuse Screening Test
self-report instrument measuring frequency and volume of non-alcohol related substance use; score range = 0-10, with higher scores indicating more severe drug use
Time frame: Six times over course of 52 weeks
DBT-J Case Management Checklist
self-report instrument measuring nature and severity of common case management difficulties; score range = 0-3, with higher scores indicating broader, more severe difficulties
Time frame: Six times over course of 52 weeks
Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form
self-report instrument measuring quality of life and perceived satisfaction with life circumstances; score range = 16-80, with higher scores indicating greater perceived satisfaction with life circumstances
Time frame: Six times over course of 52 weeks
Connor-Davidson Resilience Scale
self-report instrument measuring mental and emotional resilience; score range = 0-4, with higher scores indicating greater resilience
Time frame: Six times over course of 52 weeks
Suicide attempt
self-reported or medical chart-documented suicide attempt
Time frame: 52 weeks
Criminal recidivism
new official record-documented arrest, violation, or order of protection filed
Time frame: 52 weeks
Screen for Nonsuicidal Self Injury
self-report instrument measuring nature and frequency of nonsuicidal self-injury; score range = 0-50, with higher scores indicating greater variation in and frequency of nonsuicidal self-injury
Time frame: Three times over course of 52 weeks
Difficulties in Emotion Regulation Scale-18
self-report instrument measuring difficulties in emotion regulation; score range = 18-90, with higher scores indicating greater difficulties in emotion regulation
Time frame: Six times over course of 52 weeks
Triarchic Psychopathy Measure
self-report instrument measuring personality traits commonly associated with psychopathy; score range = 0-3, with higher scores indicating more severe psychopathic personality traits
Time frame: Three times over course of 52 weeks
Plan to share: No — To preserve participant confidentiality, individual participant data will not be shared with anyone outside of the immediate research team.
Started Jan 2024 (actual). Primary completion is estimated for Jun 2027, 41 months after the start.
Of 20 interventional studies with no phase under Recidivism, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 65. This study's planned 41 months is close to that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development →